Stoke Therapeutics to Present at the 2022 Jefferies Healthcare Conference

Author's Avatar
Jun 01, 2022

Stoke+Therapeutics%2C+Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the 2022 Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 4:00 p.m. ET.